MedTrace Logo

Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression

NCT05063604 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-07-05

No results posted yet for this study

Summary

To provide evidence on the antidepressant efficacy of two therapeutic treatments: pharmacological treatment (citalopram) and psychotherapy treatment, in women diagnosed with breast cancer and major depression.

Conditions

Interventions

DRUG

Citalopram

20 mg tablet one or twice daily for 12 weeks

BEHAVIORAL

Psychotherapy

One session weekly for 12 weeks

Sponsors & Collaborators

  • Institut Català d'Oncologia

    collaborator OTHER

  • Hospital Universitari de Bellvitge

    lead OTHER

Principal Investigators

  • Cinto Segalàs, MD, PhD. · Psychiatrist at the Bellvitge University Hospital.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2022-05-10
Completion
2022-06-29

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05063604 on ClinicalTrials.gov